Taro Pharmaceutical Industries Net Profit Margin 2006-2019 | TARO

Taro Pharmaceutical Industries net profit margin from 2006 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Taro Pharmaceutical Industries Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-03-31 $0.67B $0.28B 42.09%
2018-12-31 $0.67B $0.31B 46.62%
2018-09-30 $0.64B $0.23B 36.34%
2018-06-30 $0.66B $0.22B 34.05%
2018-03-31 $0.66B $0.21B 31.77%
2017-12-31 $0.68B $0.21B 30.35%
2017-09-30 $0.75B $0.33B 44.04%
2017-06-30 $0.81B $0.40B 49.75%
2017-03-31 $0.88B $0.46B 51.99%
2016-12-31 $0.95B $0.49B 51.58%
2016-09-30 $0.99B $0.54B 54.56%
2016-06-30 $0.97B $0.55B 56.45%
2016-03-31 $0.95B $0.54B 56.95%
2015-12-31 $0.93B $0.58B 62.22%
2015-09-30 $0.91B $0.53B 58.42%
2015-06-30 $0.95B $0.54B 57.07%
2015-03-31 $0.86B $0.48B 55.97%
2014-12-31 $0.81B $0.42B 52.23%
2014-09-30 $0.78B $0.40B 50.51%
2014-06-30 $0.74B $0.35B 47.28%
2014-03-31 $0.76B $0.36B 47.56%
2013-12-31 $0.74B $0.32B 43.42%
2013-09-30 $0.71B $0.29B 41.33%
2013-06-30 $0.67B $0.26B 39.40%
2013-03-31 $0.67B $0.27B 39.64%
2012-12-31 $0.65B $0.26B 40.55%
2012-09-30 $0.61B $0.24B 38.66%
2012-06-30 $0.59B $0.23B 39.15%
2012-03-31 $0.54B $0.20B 37.57%
2011-12-31 $0.51B $0.18B 36.17%
2011-09-30 $0.46B $0.13B 27.17%
2011-06-30 $0.43B $0.09B 20.00%
2011-03-31 $0.41B $0.07B 16.55%
2010-12-31 $0.39B $0.05B 13.27%
2010-09-30 $0.38B $0.06B 15.73%
2010-06-30 $0.37B $0.05B 13.66%
2010-03-31 $0.37B $0.04B 11.78%
2009-12-31 $0.28B $0.03B 11.96%
2009-09-30 $0.28B $0.04B 14.49%
2009-06-30 $0.27B $0.04B 15.81%
2009-03-31 $0.18B $0.03B 17.71%
2008-12-31 $0.18B $0.03B 17.71%
2008-09-30 $0.17B $0.02B 10.65%
2007-12-31 $0.15B $-0.00B -2.04%
2006-12-31 $0.22B $-0.00B -0.45%
2006-03-31 $0.30B $0.01B 1.67%
2005-12-31 $0.30B $0.01B 1.67%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.358B $0.670B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.500B 34.82
Takeda Pharmaceutical (TAK) Japan $27.482B 8.07
Grifols (GRFS) Spain $13.834B 17.50
Sage Therapeutics (SAGE) United States $9.115B 0.00
Ionis Pharmaceuticals (IONS) United States $9.045B 19.77
Catalent (CTLT) United States $7.746B 31.09
Jazz Pharmaceuticals (JAZZ) Ireland $7.731B 10.60
Neurocrine Biosciences (NBIX) United States $7.379B 0.00
Nektar Therapeutics (NKTR) United States $6.035B 9.84
Tilray (TLRY) Canada $4.551B 0.00
FibroGen (FGEN) United States $3.642B 0.00
United Therapeutics (UTHR) United States $3.385B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.609B 393.14
PTC Therapeutics (PTCT) United States $2.455B 0.00
Xencor (XNCR) United States $2.173B 59.32
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.968B 7.09
USANA Health Sciences (USNA) United States $1.816B 15.78
Pacira Pharmaceuticals (PCRX) United States $1.799B 87.12
Portola Pharmaceuticals (PTLA) United States $1.755B 0.00
Tricida (TCDA) United States $1.727B 0.00
Zogenix (ZGNX) United States $1.677B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.615B 22.07
Ironwood Pharmaceuticals (IRWD) United States $1.607B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.520B 0.00
Heron Therapeutics (HRTX) United States $1.436B 0.00
Aerie Pharmaceuticals (AERI) United States $1.356B 0.00
Turning Point Therapeutics (TPTX) United States $1.323B 0.00
Esperion Therapeutics (ESPR) United States $1.319B 0.00
Corcept Therapeutics (CORT) United States $1.186B 16.93
ArQule (ARQL) United States $1.186B 0.00
Radius Health (RDUS) United States $1.068B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.943B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.899B 0.00
Endo (ENDP) Ireland $0.837B 1.35
Aptorum Group (APM) China $0.761B 0.00
Odonate Therapeutics (ODT) United States $0.752B 0.00
CannTrust Holdings (CTST) Canada $0.686B 0.00
Organogenesis Holdings (ORGO) United States $0.670B 0.00
Translate Bio (TBIO) United States $0.633B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.595B 0.00
TherapeuticsMD (TXMD) United States $0.593B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.567B 0.00
Akebia Therapeutics (AKBA) United States $0.522B 0.00
Dermira (DERM) United States $0.516B 0.00
ChemoCentryx (CCXI) United States $0.506B 0.00
GlycoMimetics (GLYC) United States $0.492B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Siga Technologies (SIGA) United States $0.440B 1.04
Flexion Therapeutics (FLXN) United States $0.429B 0.00
Collegium Pharmaceutical (COLL) United States $0.421B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.421B 21.25
BioCryst Pharmaceuticals (BCRX) United States $0.399B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.373B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.371B 0.00
Rafael Holdings (RFL) United States $0.370B 0.00
Karyopharm Therapeutics (KPTI) United States $0.358B 0.00
KalVista Pharmaceuticals (KALV) United States $0.355B 0.00
TCR2 Therapeutics (TCRR) United States $0.351B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.348B 0.00
Forty Seven (FTSV) United States $0.339B 0.00
Harpoon Therapeutics (HARP) United States $0.303B 0.00
OptiNose (OPTN) United States $0.294B 0.00
Xeris Pharmaceuticals (XERS) United States $0.291B 0.00
Dova Pharmaceuticals (DOVA) United States $0.289B 0.00
Molecular Templates (MTEM) United States $0.289B 0.00
CASI Pharmaceuticals (CASI) United States $0.286B 0.00
Concert Pharmaceuticals (CNCE) United States $0.275B 0.00
ImmunoGen (IMGN) United States $0.272B 0.00
Aratana Therapeutics (PETX) United States $0.256B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.244B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.230B 0.00
Lannett Co Inc (LCI) United States $0.223B 2.17
Recro Pharma (REPH) United States $0.219B 0.00
Minerva Neurosciences (NERV) United States $0.217B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.205B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.193B 0.00
Bio Blast Pharma (ENLV) Israel $0.187B 0.00
MEI Pharma (MEIP) United States $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.182B 0.00
Ocular Therapeutix (OCUL) United States $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.179B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.173B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.172B 0.00
Aldeyra Therapeutics (ALDX) United States $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.164B 53.06
Ardelyx (ARDX) United States $0.157B 0.00
Calithera Biosciences (CALA) United States $0.147B 0.00
AgeX Therapeutics (AGE) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.146B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.141B 0.00
Redhill Biopharma (RDHL) Israel $0.140B 0.00
IMV INC (IMV) Canada $0.139B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.138B 0.00
Majesco Entertainment (PTE) United States $0.136B 0.00
Neon Therapeutics (NTGN) United States $0.131B 0.00
Tyme Technologies (TYME) United States $0.115B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.115B 0.00
DURECT (DRRX) United States $0.106B 0.00
Aquestive Therapeutics (AQST) United States $0.105B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.102B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 70.56
Avenue Therapeutics (ATXI) United States $0.099B 0.00
Infinity Pharmaceuticals (INFI) United States $0.096B 0.00
Cardiome Pharma (CORV) Canada $0.095B 0.00
Champions Oncology (CSBR) United States $0.094B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.093B 0.00
China SXT Pharmaceuticals (SXTC) China $0.092B 0.00
Mast Therapeutics (SVRA) United States $0.087B 0.00
Natural Alternatives (NAII) United States $0.087B 8.72
MediWound (MDWD) Israel $0.087B 0.00
Iterum Therapeutics (ITRM) Ireland $0.085B 0.00
Nivalis Therapeutics (ALPN) United States $0.084B 0.00
Capnia (SLNO) United States $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Adherex Technologies (FENC) United States $0.077B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
Melinta Therapeutics (MLNT) United States $0.070B 0.00
Novan (NOVN) United States $0.070B 0.00
India Globalization Capital (IGC) United States $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.061B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.060B 0.00
CTI BioPharma (CTIC) United States $0.054B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Genocea Biosciences (GNCA) United States $0.049B 0.00
Forward Pharma (FWP) Denmark $0.049B 0.00
Zafgen (ZFGN) United States $0.048B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.045B 0.00
KemPharm (KMPH) United States $0.044B 0.00
ProNAi Therapeutics (SRRA) Canada $0.043B 0.00
Opexa Therapeutics (ACER) United States $0.042B 0.00
BioLineRx (BLRX) Israel $0.041B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
ContraFect (CFRX) United States $0.040B 0.00
Bio-Path Holdings (BPTH) United States $0.037B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
PharmAthene (ALT) United States $0.029B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.029B 0.00
ProPhase Labs (PRPH) United States $0.029B 0.00
IsoRay (ISR) United States $0.028B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Heat Biologics (HTBX) United States $0.024B 0.00
GTx (ONCT) United States $0.024B 0.00
Pain Therapeutics (SAVA) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.61
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
Shineco (TYHT) China $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.013B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.80
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00